Literature DB >> 7490555

Growth hormone (GH) receptor and GH-binding protein deficiency in the growth failure of potassium-depleted rats.

Z Hochberg1, T Amit, A Flyvbjerg, I Dørup.   

Abstract

Potassium (K+) deficiency is associated with growth retardation in both man and experimental animals. Growth hormone (GH) administration to such animals prevents, to some extent, weight loss and selective muscle atrophy, but does not affect tail and tibia length even with supraphysiological doses. The present study was undertaken to investigate the possible effect of K+ deficiency on the hepatic GH receptor and GH-binding protein (BP). Young female Wistar rats were maintained on K(+)-deficient fodder and distilled water, and compared with pair-fed and ad-libitum-fed control groups. After 15 days GH-BP and electrolytes were measured in sera, GH receptors were studied in liver membranes by 125I-labeled human GH binding and muscles were weighed and saved for electrolyte measurements. K(+)-deficient rats showed complete growth arrest compared with an intermediate weight gain of the pair-fed group. Serum K+ was very low, at 1.5 +/- 0.1 mmol/l, compared with the mean value of 5.3 mmol/l of control animals. Somatogenic and lactogenic receptors in liver membranes and serum GH-BP levels were significantly (P < 0.05) lower in K+ deficiency, as compared with their pair-fed controls. Liver GH receptors correlated significantly (P < 0.05) with serum GH-BP levels. The growth variables correlated positively with both hepatic somatogenic and lactogenic receptors and serum GH-BP levels, with correlation coefficients that were highest against serum GH-BP and lowest against liver lactogenic receptors. Serum and muscle K+ correlated significantly (P < 0.05) with both liver GH receptors and serum GH-BP, with correlation coefficients that were higher against serum GH-BP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490555     DOI: 10.1677/joe.0.1470253

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Gitelman syndrome combined with complete growth hormone deficiency.

Authors:  Se Ra Min; Hyun Seok Cho; Jeana Hong; Hae Il Cheong; Sung Yeon Ahn
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

2.  Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Authors:  Elsa Seys; Olga Andrini; Mathilde Keck; Lamisse Mansour-Hendili; Pierre-Yves Courand; Christophe Simian; Georges Deschenes; Theresa Kwon; Aurélia Bertholet-Thomas; Guillaume Bobrie; Jean Sébastien Borde; Guylhène Bourdat-Michel; Stéphane Decramer; Mathilde Cailliez; Pauline Krug; Paul Cozette; Jean Daniel Delbet; Laurence Dubourg; Dominique Chaveau; Marc Fila; Noémie Jourde-Chiche; Bertrand Knebelmann; Marie-Pierre Lavocat; Sandrine Lemoine; Djamal Djeddi; Brigitte Llanas; Ferielle Louillet; Elodie Merieau; Maria Mileva; Luisa Mota-Vieira; Christiane Mousson; François Nobili; Robert Novo; Gwenaëlle Roussey-Kesler; Isabelle Vrillon; Stephen B Walsh; Jacques Teulon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  J Am Soc Nephrol       Date:  2017-04-05       Impact factor: 10.121

Review 3.  Longitudinal growth in chronic hypokalemic disorders.

Authors:  Helena Gil-Peña; Natalia Mejia; Oscar Alvarez-Garcia; Vanessa Loredo; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

4.  Bartter syndrome and growth hormone deficiency: three cases.

Authors:  Mithat Buyukcelik; Mehmet Keskin; Beltinge Demircioglu Kilic; Yilmaz Kor; Ayse Balat
Journal:  Pediatr Nephrol       Date:  2012-06-16       Impact factor: 3.714

Review 5.  Bartter syndrome: causes, diagnosis, and treatment.

Authors:  Tamara da Silva Cunha; Ita Pfeferman Heilberg
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.